Strategies for selecting membrane protein-specific antibodies using phage display with cell-based panning

MA Alfaleh, ML Jones, CB Howard, SM Mahler - Antibodies, 2017 - mdpi.com
Membrane proteins are attractive targets for monoclonal antibody (mAb) discovery and
development. Although several approved mAbs against membrane proteins have been …

Regulation mechanism of ferroptosis and its research progress in tumor immunotherapy

J Xu, X Lin, T Han, Q Zhou, Y Su, S Jiang… - Frontiers in Molecular …, 2022 - frontiersin.org
Ferroptosis is a novel regulatory cell death, which is characterized by iron dependency and
mainly caused by accumulation of intracellular lipid peroxides and reactive oxygen species …

ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy

SL Harwood, A Alvarez-Cienfuegos… - …, 2018 - Taylor & Francis
The redirection of T cell activity using bispecific antibodies is one of the most promising
cancer immunotherapy approaches currently in development, but it is limited by cytokine …

Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer

H Liu, L Ma, J Lin, B Cao, D Qu, C Luo, W Huang… - Pharmacological …, 2020 - Elsevier
Breast cancer remains the leading cause of cancer-related death among women worldwide,
and its incidence is also increasing. High recurrence rate and metastasis rate are the key …

Geometry and expression enhance enrichment of functional yeast‐displayed ligands via cell panning

LA Stern, IA Schrack, SM Johnson… - Biotechnology and …, 2016 - Wiley Online Library
Yeast surface display has proven to be an effective tool in the discovery and evolution of
ligands with new or improved binding activity. Selections for binding activity are generally …

[HTML][HTML] Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates

MA Khiavi, A Safary, MH Somi - BioImpacts: BI, 2019 - ncbi.nlm.nih.gov
Despite rapid advances in diagnostic and treatment approaches, the overall survival rate of
cancer has not been improved. Colorectal cancer (CRC) is recognized as the third leading …

Bispecific antibody format and the organization of immunological synapses in T cell-redirecting strategies for cancer immunotherapy

C Carrasco-Padilla, A Hernaiz-Esteban… - Pharmaceutics, 2022 - mdpi.com
T cell-redirecting strategies have emerged as effective cancer immunotherapy approaches.
Bispecific antibodies (bsAbs) are designed to specifically recruit T cells to the tumor …

Bispecific light T-cell engagers for gene-based immunotherapy of epidermal growth factor receptor (EGFR)-positive malignancies

K Mølgaard, SL Harwood, M Compte, N Merino… - Cancer Immunology …, 2018 - Springer
The recruitment of T-cells by bispecific antibodies secreted from adoptively transferred, gene-
modified autologous cells has shown satisfactory results in preclinical cancer models. Even …

Genetically modified bacteriophages

AP Sagona, AM Grigonyte, PR MacDonald… - Integrative …, 2016 - academic.oup.com
Phages or bacteriophages, viruses that infect and replicate inside bacteria, are the most
abundant microorganisms on earth. The realization that antibiotic resistance poses a …

A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer

W Hou, Q Yuan, X Yuan, Y Wang, W Mo, H Wang… - Investigational new …, 2019 - Springer
Background Redirecting T cells to tumor cells using bispecific antibodies (BsAbs) is
emerging as a potent cancer therapy. The main concept of this strategy is to cross-link tumor …